| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |